News
MedPal AI Hits £8.6m Revenue Run Rate…. It’s Just Getting Started
MedPal AI CEO Jason Drummond discusses the Group’s rapid rise to an £8.6 million annualised revenue run rate, record NHS prescription volumes and the strong launch of New Health. He also explains how cross-selling across the Group’s three recurring revenue streams could support its next phase of growth.
CEO Jason Drummond discusses the Group’s rapid rise to an £8.6 million annualised revenue run rate, record NHS prescription volumes and the strong launch of New Health. He also explains how cross-selling across the Group’s three recurring revenue streams could support its next phase of growth.
